)
)
Mirati Therapeutics Investor Relations Material
Latest events
Q2 2023
Mirati Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Mirati Therapeutics Inc
Access all reports
Mirati Therapeutics Inc. is a clinical-stage biotechnology company focused on developing targeted cancer therapies. The company specializes in the research and development of treatments aimed at addressing genetic and epigenetic drivers of cancer. Mirati’s pipeline includes precision oncology candidates designed to inhibit specific molecular targets associated with tumor growth and progression. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
MRTX
Country
🇺🇸 United States